DSGN Design Therapeutics, Inc.
$10.63▲ +2.80%
Healthcare
Other
After hours
$10.63▲ +0.00%
Oct 27, 4:01 PM ET
Volume 388.9K
Avg Volume (10D) 519.9K
Key Metrics & Fundamentals
Market Cap
$665.24M
P/E Ratio
–
Div Yield
0.00%
52W Range
6.16 - 17.25
% vs 50 MA
-17.81%
% vs 200 MA
-12.47%
RSI-14
41.0
MACD Histogram
+0.0600
Beta (1Y vs SPY)
1.08
Free Cash Flow
-$15.55M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$22.03M
COGS
–
Operating Exp
$22.18M
Operating Income
-$22.18M
EBIT
-$22.18M
Pretax Income
-$20.17M
Net Income
-$20.17M
EPS (Diluted)
-0.32
Price & Volume History
Loading chart…
Recent News
Nike downgraded, Airbnb upgraded: Wall Street's top analyst calls
The Fly · Oct 2, 2026 9:40 AM ET
Wells Fargo Initiates Design Therapeutics at Overweight With $26 Price Target
MT Newswires · Oct 2, 2026 5:48 AM ET
Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference
GlobeNewswire · Sep 2, 2026 8:00 AM ET
Wall Street Moves on MAA, Rivian and Design Therapeutics: One Upgrade, One Target Trim and a Biotech on Watch
24/7 Wall St. · Aug 27, 2026 10:00 AM ET
Design Therapeutics Q2 Net Loss Narrows
MT Newswires · Aug 3, 2026 8:43 AM ET
Design Therapeutics Provides RESTORE-FA Clinical Development Update and Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 3, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See DSGN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.